News

Targeted Oncology17h
Zanzalintinib/Atezolizumab Improves CRC Survival, Expands TKI's Role in Solid Tumors
New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...
New immuno-pet tracer superior to FDG PET in predicting PD-L1 expression in head and neck cancer
PCP2, can effectively measure PD-L1 expression in patients with head and neck cancers, outperforming the conventional tracer ...
DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non ...
PipelineReview.com4h
Results from Amgen’s phase 2 obesity study of monthly maritide presented at the American Diabetes Association 85th scientific sessions
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and ...